SCHEMBL3663665

SCHEMBL3663665

Cc1c(C)c2c(c(C)c1O)CCC(C)(C(=O)NC(C)C(O)I)O2

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.61
PTGS2 P35354 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
TSHR P16473 1/20 0.61
CAPN1 P07384 1/20 0.54
NR1I2 O75469 2/20 0.43
ALOX5 P09917 1/20 0.43
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
GSTP1 P09211 1/20 0.42
TTPA P49638 1/20 0.42
KMT2A Q03164 1/20 0.42
USP2 O75604 1/20 0.42
THRB P10828 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ACHE P22303 10/20 0.42
BCHE P06276 9/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15820150 0.86 PTGS1 (0.72) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL20764606 0.83 PTGS1 (0.67) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL17289287 0.82 PTGS1 (0.62) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL2059506 0.82 PTGS1 (0.62) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL23496435 0.81 PTGS1 (0.61) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL2059478 0.80 PTGS1 (0.62) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL15821003 0.79 PTGS1 (0.74) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL15820288 0.79 PTGS1 (0.74) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL15820289 0.79 PTGS1 (0.74) PTGS1PTGS2CYP1A2CYP3A4TSHR
SCHEMBL18934019 0.79 PTGS1 (0.74) PTGS1PTGS2CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2220030-A2 4- (P-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES Edison Pharmaceuticals, Inc. (US) 2010-08-25 EP disclosed
WO-2009061744-A2 4- (P-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES EDISON PHARMACEUTICALS, INC. (US) 2009-05-14 WO disclosed